Results for: Subcutaneous Injection
Find the latest Subcutaneous Injection tenders from different organizations. SigmaTenders helps you participate in these online e-Procurement tenders. We provide access to tender details, BOQs, and technical bids, along with bidding support for Subcutaneous Injection e-tenders. Stay informed with daily email alerts and comprehensive coverage across government websites, GeM, and e-Procurement portals.
Intramuscular, intradermal, subcutaneous injection trainer,intravenous training pad,female urinary
Intramuscular, intradermal, subcutaneous injection trainer,intravenous training pad,female urinary
Child cpr,baby cpr,iv access trainer,subcutaneous, intradermal, intramuscular injection trainer,int
Child cpr,baby cpr,iv access trainer,subcutaneous, intradermal, intramuscular injection trainer,int
Insulin degludec (r-dna origin) solution for subcutaneous injection. 1 ml of the solution contains 100 units of insulin degludec equivalent to 3.66 mg, one prefilled pen contain 300 unit of insulin degludec in 03 ml solution
For complete deion and other details, please refer to tender
Insulin degludec (r- dna origin) solution for subcutaneous injection , 1 ml of solution contains 100 unit of insulin degludec equivalent to 3.66 mg , one prefilled pen contain 300 unit of insulin degludec in 03 ml solution in pfs
Insulin degludec (r- dna origin) solution for subcutaneous injection , 1 ml of solution contains 100 unit of insulin degludec equivalent to 3.66 mg , one prefilled pen contain 300 unit of insulin degludec in 03 ml solution in pfs
Monocomponent biosynthetic r-dna insulin- insulin detemir 100iu/ml injection in a prefilled pen for subcutaneous use
For complete deion and other details, please refer to tender
Monocomponent biosynthetic r-dna insulin- insulin detemir 100iu/ml injection in a prefilled pen for subcutaneous use
For complete deion and other details, please refer to tender
Monocomponent biosynthetic r-dna insulin- insulin detemir 100iu/ml injection in a prefilled pen for subcutaneous use
For complete deion and other details, please refer to tender
Recombinant dna origin monocomponent insulin lispro 100iu/ml 3ml solution for injection in a pre-filled pen for subcutaneous use (junior)
For complete deion and other details, please refer to tender
๐ Procurement Opportunity: Recombinant DNA Origin Insulin Lispro Injection ๐ The Ministry of Railways, under the Central Government, invites tenders for the supply of Recombinant DNA Origin Insulin Lispro in a 100IU/ml, 3ml pre-filled pen for subcutaneous use (Junior). ๐ ๐ Tender Submission Deadline: June 18, 2024, 10:30 AM Interested bidders are requested to submit detailed tenders, including all necessary documentation and compliance with the tender specifications. Keywords: Recombinant DNA Origin Insulin, Lispro, Injection, Pre-filled Pen, Subcutaneous Use, Junior, Ministry of Railways, Central Government Tender, Hubli
Need support responding to this opportunity?
Get matched through GetSaarthi for documentation, proposal preparation, compliance readiness, and execution support.
Get Opportunity Matching Supportof your Industry type